Continent Urinary Diversion

The pelvic exenteration represents the keystone of surgical therapy for women with recurrent or advanced gynecologic tumors. In cases of gynecologic cancers, the most common indication for pelvic exenteration is recurrent cervical cancer (1). Patients with selected locally advanced International Federation of Gynecology and Obstetrics (FIGO) stage IVA cervical cancer could also benefit from this type of surgical treatment (1). In cases of ovarian cancer, in order to achieve optimal cytoreduction when there is no cleavage plane between the pelvic mass and the rectum, posterior pelvic exenteration is the best choice (2). In cases of endometrial, vaginal, or vulvar cancer, this destructive surgical procedure is proposed primarily for recurrent disease.